Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/IN/Fort Wayne
Updated October 2026 from ClinicalTrials.gov

Paid Clinical Trials in Fort Wayne, IN

Studies commonly pay $75 to $4,500 per completed study

117 clinical trials are currently recruiting participants within 30 miles of Fort Wayne. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

117studies recruiting
2+research centers nearby
4condition categories
Live from the NIH registry

Studies recruiting near Fort Wayne right now

Top 25 of 117 recruiting studies, sorted by proximity — each links to its official registry page

Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer

Endometrial Cancer Phase 2, Phase 3 Interventional 268 participants sought
Parkview Research Center — Fort Wayne, Indiana (3.0 mi) · Sponsor: Kartos Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT05797831)

A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)

Advanced Renal Cell Carcinoma (RCC) Phase 1, Phase 2 Interventional 474 participants sought
Local Institution - 0170 — Fort Wayne, Indiana (3.0 mi) · Sponsor: Bristol-Myers Squibb
See eligibility & contact on ClinicalTrials.gov (NCT07293351)

Families of Youth with Developmental Disabilities: a Theory-Based Intervention

Family Conflict, Marital Conflict N/A Interventional 150 participants sought
Wm. J. Shaw Center for Children and Families — Fort Wayne, Indiana (3.0 mi) · Sponsor: University of Notre Dame
See eligibility & contact on ClinicalTrials.gov (NCT03495440)

A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer

Small Cell Lung Cancer Phase 2 Interventional 180 participants sought
Fort Wayne Medical Oncology And Hematology /ID# 277336 — Fort Wayne, Indiana (3.0 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT07155174)

A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)

Alzheimer Disease Phase 4 Interventional 150 participants sought
NexGen Research — Fort Wayne, Indiana (3.0 mi) · Sponsor: Alpha Cognition, Inc
See eligibility & contact on ClinicalTrials.gov (NCT07633470)

Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1

Focal Seizure, Epilepsy Phase 3 Interventional 333 participants sought
Indiana University Health Fort Wayne Neurology — Fort Wayne, Indiana (3.0 mi) · Sponsor: Rapport Therapeutics Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07563881)

A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer, c-MET Phase 2, Phase 3 Interventional 490 participants sought
Parkview Research Center /ID# 277651 — Fort Wayne, Indiana (3.0 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT07155187)

Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer

Early-stage Breast Cancer, Hormone Receptor Positive Breast Carcinoma Phase 2 Interventional 88 participants sought
Ft. Wayne Medical Oncology and Hematology, Inc. — Fort Wayne, Indiana (3.0 mi) · Sponsor: Jonsson Comprehensive Cancer Center
See eligibility & contact on ClinicalTrials.gov (NCT04553770)

LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

Metastatic Non-small Cell Lung Cancer Phase 3 Interventional 734 participants sought
Parkview Packnett Family Cancer Institute — Fort Wayne, Indiana (3.0 mi) · Sponsor: NovoCure GmbH
See eligibility & contact on ClinicalTrials.gov (NCT06216301)

A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)

Idiopathic Hypersomnia Phase 3 Interventional 248 participants sought
Fort Wayne Neurological Center — Fort Wayne, Indiana (3.0 mi) · Sponsor: Harmony Biosciences Management, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07500090)

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Phase 2, Phase 3 Interventional 613 participants sought
Radiation Oncology Associates PC — Fort Wayne, Indiana (3.0 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT01810913)

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

Large B-cell Lymphoma Phase 2 Interventional 250 participants sought
Fort Wayne Medical Oncology and Hematology — Fort Wayne, Indiana (3.0 mi) · Sponsor: Allogene Therapeutics
See eligibility & contact on ClinicalTrials.gov (NCT06500273)

A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

Ovarian Cancer Phase 2 Interventional 160 participants sought
Parkview Research Center — Fort Wayne, Indiana (3.0 mi) · Sponsor: Incyte Corporation
See eligibility & contact on ClinicalTrials.gov (NCT07023627)

A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)

Heart Failure With Preserved Ejection Fraction Phase 2 Interventional 90 participants sought
Local Institution - 26 — Fort Wayne, Indiana (3.0 mi) · Sponsor: Edgewise Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07795814)

A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

Multiple Myeloma Phase 2, Phase 3 Interventional 680 participants sought
Fort Wayne Medical Oncology And Hematology /ID# 278141 — Fort Wayne, Indiana (3.0 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT07095452)

A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

Non-small Cell Lung Cancer (NSCLC) Phase 3 Interventional 850 participants sought
Fort Wayne Medical Oncology and Hematology — Fort Wayne, Indiana (3.0 mi) · Sponsor: Bristol-Myers Squibb
See eligibility & contact on ClinicalTrials.gov (NCT07361497)

A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer

Prostate Cancer, Metastatic Castration Resistant Prostate Cancer Phase 1 Interventional 174 participants sought
Fort Wayne Medical Oncology and Hematology, Inc. — Fort Wayne, Indiana (3.0 mi) · Sponsor: Astellas Pharma Global Development, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT04729114)

A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

Diffuse Large B-Cell Lymphoma Phase 3 Interventional 1,046 participants sought
Fort Wayne Medical Oncology and Hematology ( Site 0149) — Fort Wayne, Indiana (3.0 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06717347)

ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors

Non Small Cell Lung Cancer Phase 3 Interventional 630 participants sought
Fort Wayne Medical Oncology - 1133 — Fort Wayne, Indiana (3.0 mi) · Sponsor: OncoC4, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT05671510)

A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma Phase 1 Interventional 210 participants sought
Fort Wayne Medical Oncology And Hematology /ID# 268179 — Fort Wayne, Indiana (3.0 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT05650632)
Actively enrolling

Studies you may be able to join near Fort Wayne

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Fort Wayne

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Salus Research

★ 5.0
1220 Medical Park Dr A, Fort Wayne, IN 46825
(260) 755-1099
"Best of everything! Ten stars out of five!!"
— Bruce Wilder, 5★

Avenues Recovery Center at Fort Wayne

★ 4.9 (957 reviews)
2626 Fairfield Ave, Fort Wayne, IN 46807
(260) 909-8343
"I chose Avenues Ft. Wayne and have not one time felt regret over the decision.<br>The beds here are comfortable.<br>The rooms and facilities are clea…"
— Jonathan Buuck, 5★

Clinical trials in Fort Wayne: what's recruiting

The Fort Wayne area currently has 117 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Fort Wayne, the most active research areas are:

  • Cancer & Oncology18 studies
  • Liver & Kidney2 studies
  • Heart & Vascular2 studies
  • Brain & Mental Health1 studies

Every listing shows the study phase, the recruiting site and its distance from Fort Wayne, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Fort Wayne

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Fort Wayne participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Fort Wayne pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Do I need to be sick to join a clinical trial in Fort Wayne?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
What is the difference between a research center and a hospital study in Fort Wayne?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Fort Wayne?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Fort Wayne.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Fort Wayne typically complete one or two studies per year.

Paid clinical trials near Fort Wayne

Other metros within reach

Elkhart, IN104 Kalamazoo, MI101 South Bend, IN104 Dayton, OH307 Indianapolis, IN946 Toledo, OH210 Lansing, MI168 Ann Arbor, MI1,171

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Fort Wayne Bladder Issues Due To Spinal Cord Injury in Fort Wayne All conditions

More of IN

Indianapolis946 Elkhart104 South Bend104 Evansville76 Lafayette34

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts